Leuthold Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.08M | Buy |
33,143
+554
| +2% | +$102K | 0.65% | 59 |
|
|
2025
Q4 | $5.74M | Buy |
32,589
+9,072
| +39% | +$1.48M | 0.62% | 58 |
|
|
2025
Q3 | $3.29M | Buy |
+23,517
| New | +$3.18M | 0.36% | 105 |
|
|
2021
Q1 | – | Sell |
-10,358
| Closed | -$2.54M | – | 180 |
|
|
2020
Q4 | $2.54M | Sell |
10,358
-5,280
| -34% | -$1.36M | 0.33% | 109 |
|
|
2020
Q3 | $4.44M | Sell |
15,638
-811
| -5% | -$226K | 0.61% | 58 |
|
|
2020
Q2 | $4.4M | Buy |
16,449
+99
| +0.6% | +$29.8K | 0.66% | 57 |
|
|
2020
Q1 | $5.17M | Sell |
16,350
-1,513
| -8% | -$459K | 0.93% | 32 |
|
|
2019
Q4 | $5.3M | Buy |
+17,863
| New | +$4.96M | 0.69% | 60 |
|
|
2019
Q3 | – | Sell |
-14,291
| Closed | -$3.34M | – | 177 |
|
|
2019
Q2 | $3.34M | Sell |
14,291
-772
| -5% | -$178K | 0.43% | 94 |
|
|
2019
Q1 | $3.56M | Buy |
15,063
+5,566
| +59% | +$1.75M | 0.48% | 83 |
|
|
2018
Q4 | $2.86M | Sell |
9,497
-603
| -6% | -$192K | 0.41% | 93 |
|
|
2018
Q3 | $3.57M | Buy |
+10,100
| New | +$3.48M | 0.39% | 100 |
|
|
2018
Q1 | – | Sell |
-24,619
| Closed | -$7.84M | – | 197 |
|
|
2017
Q4 | $7.84M | Buy |
24,619
+5,648
| +30% | +$1.81M | 0.78% | 36 |
|
|
2017
Q3 | $5.94M | Sell |
18,971
-89
| -0.5% | -$26.4K | 0.6% | 55 |
|
|
2017
Q2 | $5.17M | Sell |
19,060
-1,028
| -5% | -$272K | 0.55% | 62 |
|
|
2017
Q1 | $5.49M | Sell |
20,088
-53
| -0.3% | -$15K | 0.59% | 55 |
|
|
2016
Q4 | $5.71M | Sell |
20,141
-1,581
| -7% | -$469K | 0.64% | 48 |
|
|
2016
Q3 | $6.8M | Buy |
+21,722
| New | +$6.43M | 0.71% | 46 |
|
|
2016
Q2 | – | Sell |
-13,413
| Closed | -$3.49M | – | 210 |
|
|
2016
Q1 | $3.49M | Buy |
13,413
+274
| +2% | +$72.4K | 0.38% | 101 |
|
|
2015
Q4 | $4.03M | Buy |
13,139
+748
| +6% | +$215K | 0.42% | 99 |
|
|
2015
Q3 | $3.62M | Sell |
12,391
-2,108
| -15% | -$696K | 0.38% | 98 |
|
|
2015
Q2 | $5.86M | Buy |
14,499
+553
| +4% | +$222K | 0.55% | 55 |
|
|
2015
Q1 | $5.89M | Buy |
13,946
+66
| +0.5% | +$26K | 0.55% | 59 |
|
|
2014
Q4 | $4.71M | Buy |
+13,880
| New | +$4.49M | 0.46% | 78 |
|
|
2013
Q3 | – | Sell |
-9,979
| Closed | -$2.15M | – | 311 |
|
|
2013
Q2 | $2.15M | Buy |
+9,979
| New | +$2.13M | 0.2% | 140 |
|
Other funds holding BIIB
VCM
VPM
Leuthold Group's BIIB Position: Q1 2026 in Review
Leuthold Group increased its Biogen (BIIB) stake by 1.7% in Q1 2026, buying an estimated $102K and bringing the position to 33,143 shares worth $6.08M. The position accounts for 0.65% of the portfolio, ranked #59.
Leuthold Group first reported a position in BIIB in Q2 2013 and has held it in 25 quarters since. The position peaked at $7.84M in Q4 2017. 1,003 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Leuthold Group held 33,143 shares of Biogen worth $6.08M as of Q1 2026.
- Leuthold Group bought 554 Biogen shares in Q1 2026, an estimated $102K.
- Biogen made up 0.65% of Leuthold Group's portfolio in Q1 2026, its #59 holding.
- Leuthold Group first reported a position in Biogen in Q2 2013 and has held it in 25 quarters since.
- Leuthold Group's Biogen position peaked at $7.84M in Q4 2017.
- 1,003 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Leuthold Group's 13F filing for Q1 2026, filed 6 May 2026.